Arecor Therapeutics plc (AREC.L)
GBp 38.0
(0.0%)
GBp 38.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 220 Thousand GBP | 155.81% |
| 2022 | 86 Thousand GBP | -18.1% |
| 2021 | 105 Thousand GBP | -94.44% |
| 2020 | 1.89 Million GBP | 3029.82% |
| 2019 | 60.39 Thousand GBP | -52.98% |
| 2018 | 128.43 Thousand GBP | -77.59% |
| 2017 | 573.05 Thousand GBP | 109.45% |
| 2016 | 273.59 Thousand GBP | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - GBP | 0.0% |
| 2024 Q1 | - GBP | 0.0% |
| 2023 Q4 | 220 Thousand GBP | 0.0% |
| 2023 FY | 220 Thousand GBP | 155.81% |
| 2023 Q3 | 220 Thousand GBP | 331.37% |
| 2023 Q2 | 51 Thousand GBP | 0.0% |
| 2023 Q1 | 51 Thousand GBP | -40.7% |
| 2022 FY | 86 Thousand GBP | -18.1% |
| 2022 Q4 | 86 Thousand GBP | 0.0% |
| 2022 Q3 | 86 Thousand GBP | 104.76% |
| 2022 Q2 | 42 Thousand GBP | 0.0% |
| 2022 Q1 | 42 Thousand GBP | -60.0% |
| 2021 Q3 | 105 Thousand GBP | -37.62% |
| 2021 FY | 105 Thousand GBP | -94.44% |
| 2021 Q1 | 168.31 Thousand GBP | -91.1% |
| 2021 Q2 | 168.31 Thousand GBP | 0.0% |
| 2021 Q4 | 105 Thousand GBP | 0.0% |
| 2020 Q3 | 1.89 Million GBP | 0.0% |
| 2020 Q2 | - GBP | 0.0% |
| 2020 Q1 | - GBP | 0.0% |
| 2020 FY | 1.89 Million GBP | 3029.82% |
| 2020 Q4 | 1.89 Million GBP | 0.01% |
| 2019 FY | 60.39 Thousand GBP | -52.98% |
| 2018 FY | 128.43 Thousand GBP | -77.59% |
| 2017 FY | 573.05 Thousand GBP | 109.45% |
| 2016 FY | 273.59 Thousand GBP | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|